STARTSEITE 
MPG   Logo Psychiatrie

Aktuelle Pressemitteilung:
31.01.2012
Nasenspray gegen Panikattacken?
Veranstaltungen:
14.02.2012 17:00
Vulnerability and adverse life events in animal models of depression: focus on the role of positive affect
Jaanus Harro, MD, Ph.D
Seminarvortrag
28.02.2012 17:00
Are psychiatric drugs more or less efficacious than drugs of other medical specialities?
Prof. Dr. Stefan Leucht
Seminarvortrag
Probanden gesucht:
01.11.2011 08:00
Gesunde, übergewichtige Männer gesucht
01.12.2011 08:00
Gesunde Probandinnen gesucht

 

Christoph W. Turck

photo

Christoph W. Turck, Prof. Dr. rer. nat.

Arbeitsgruppenleiter
Text Link Intern AG Turck: Proteomik und Biomarker
Tel: 089/30622-317
Fax: 089/30622-610
Email: turck[a]mpipsykl.mpg.de
Interessen: Proteomik, Biomarker, Gehirn Erkrankungen
   
CV:
Geboren in Homberg, Deutschland. Dr. rer.nat. in Chemie, RWTH Aachen, Deutschland (1983). Postdoc, Roche Institute of Molecular Biology, Nutley, NJ, USA (1983-1986). Professor der Medizin, Direktor des Proteinstruktur Labors, University of California San Francisco, Howard Hughes Medical Institute (1986-2002). Seit 2002 Leiter der Forschungsgruppe „Proteomik und Biomarker“ am MPI für Psychiatrie.
Text Link Intern CV (pdf)
Weitere Aktivitäten:
  • Apl. Professor der Biochemie, Ludwig Maximilians Universität München
  • Fakultätsmitglied, International Max Planck Research School for Molecular and Cellular Life Sciences, München
  • Fakultätsmitglied, Graduate School of Systemic Neurosciences, München
  • fNIH Biomarkers Consortium, Neuroscience Steering Committee
  • EU Innovative Medicines Initiative, NEWMEDS, Scientific Advisory Board
  • Association of Biomolecular Research Facilities, Metabolomics Research Group
  • American Society for Mass Spectrometry, Pharmaceuticals Interest Group
Ausgewählte Publikationen:
Filiou MD, Zhang Y, Teplytska L, Reckow S, Gormanns P, Maccarrone G, Frank E, Kessler MS, Hambsch B, Nussbaumer M, Bunck M, Ludwig T, Yassouridis A, Holsboer F, Landgraf R, Turck CW. (2011) Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways. Biol Psychiatry (in press)

Zhang YY, Reckow S, Webhofer C, Boehme M, Gormanns P, Egge-Jacobsen WM, Turck CW. (2011) Proteome scale turnover analysis in live animals using stable isotope metabolic labeling. Anal Chem 83:665–1672

Gormanns P, Mueller NS, Ditzen C, Wolf S, Holsboer F, Turck CW. (2011) Phenome-transcriptome correlation unravels anxiety and depression related pathways. J Psychiatr Res 45:973-979

Ditzen C, Varadarajulu J, Czibere L, Gonik M, Targosz BS, Hambsch B, Bettecken T, Keßler MS, Frank E, Bunck M, Teplytska L, Erhardt A, Holsboer F, Müller-Myhsok B, Landgraf R, Turck CW. (2010) Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Mol Psychiatry 15:702-711

Turck CW, Falick AM, Kowalak JA, Lane WS, Lilley KS, Phinney BS, Weintraub ST, Witkowska HE, Yates NA. (2007) The Association of Biomolecular Resource Facilities Proteomics Research Group 2006 study: relative protein quantivication. Mol Cell Proteomics 6:1291-1298

Krömer SA, Keßler MS, Milfay D, Birg IN, Bunck M, Czibere L, Panhuysen M, Pütz B, Deussing JM, Holsboer F, Landgraf R, Turck CW. (2005) Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25:4375-4384